Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.23663222 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.89522293 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.89522293 |
4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.81842978 |
5 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.74311447 |
6 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.33093287 |
7 | neutrophil activation involved in immune response (GO:0002283) | 4.17240822 |
8 | cellular response to zinc ion (GO:0071294) | 4.16002142 |
9 | B cell receptor signaling pathway (GO:0050853) | 4.13034587 |
10 | positive regulation of B cell differentiation (GO:0045579) | 4.11849006 |
11 | positive regulation of interferon-alpha production (GO:0032727) | 4.09288231 |
12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.05794760 |
13 | immunoglobulin mediated immune response (GO:0016064) | 4.05134406 |
14 | regulation of B cell differentiation (GO:0045577) | 4.02544918 |
15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.00690683 |
16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.00690683 |
17 | modulation by symbiont of host immune response (GO:0052553) | 4.00690683 |
18 | positive regulation by symbiont of host defense response (GO:0052509) | 4.00690683 |
19 | modulation by symbiont of host defense response (GO:0052031) | 4.00690683 |
20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.00690683 |
21 | cellular response to exogenous dsRNA (GO:0071360) | 3.96968107 |
22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.95422257 |
23 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.93578347 |
24 | negative regulation of interleukin-12 production (GO:0032695) | 3.91434349 |
25 | positive regulation of type 2 immune response (GO:0002830) | 3.90287650 |
26 | NIK/NF-kappaB signaling (GO:0038061) | 3.89073858 |
27 | regulation of interferon-alpha production (GO:0032647) | 3.86637748 |
28 | cellular response to interferon-beta (GO:0035458) | 3.83553998 |
29 | detection of other organism (GO:0098543) | 3.83450076 |
30 | myeloid dendritic cell activation (GO:0001773) | 3.82422204 |
31 | positive regulation of antigen processing and presentation (GO:0002579) | 3.81805164 |
32 | detection of bacterium (GO:0016045) | 3.81469120 |
33 | myeloid dendritic cell differentiation (GO:0043011) | 3.72256358 |
34 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.63591606 |
35 | neutrophil activation (GO:0042119) | 3.63028140 |
36 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.59194438 |
37 | negative regulation of phagocytosis (GO:0050765) | 3.57811331 |
38 | respiratory burst (GO:0045730) | 3.55477000 |
39 | * response to type I interferon (GO:0034340) | 3.54975691 |
40 | * type I interferon signaling pathway (GO:0060337) | 3.54031752 |
41 | * cellular response to type I interferon (GO:0071357) | 3.54031752 |
42 | T-helper 1 type immune response (GO:0042088) | 3.47787529 |
43 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.46494245 |
44 | granulocyte activation (GO:0036230) | 3.45097516 |
45 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.43288139 |
46 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.42281671 |
47 | macrophage activation involved in immune response (GO:0002281) | 3.42258363 |
48 | regulation of antigen processing and presentation (GO:0002577) | 3.40338653 |
49 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.36718187 |
50 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.36659199 |
51 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.35941801 |
52 | interferon-gamma production (GO:0032609) | 3.33875809 |
53 | B cell proliferation (GO:0042100) | 3.33093664 |
54 | positive regulation of B cell proliferation (GO:0030890) | 3.31383931 |
55 | natural killer cell mediated immunity (GO:0002228) | 3.29903615 |
56 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.29903615 |
57 | negative regulation of B cell proliferation (GO:0030889) | 3.29590791 |
58 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.29085576 |
59 | response to host immune response (GO:0052572) | 3.29085576 |
60 | * cellular response to interferon-gamma (GO:0071346) | 3.28997652 |
61 | response to muramyl dipeptide (GO:0032495) | 3.27693894 |
62 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.26380480 |
63 | regulation of germinal center formation (GO:0002634) | 3.24664499 |
64 | regulation of gamma-delta T cell activation (GO:0046643) | 3.24488405 |
65 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.23042363 |
66 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.22058441 |
67 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.19652019 |
68 | B cell mediated immunity (GO:0019724) | 3.18370958 |
69 | positive regulation of B cell activation (GO:0050871) | 3.17002973 |
70 | positive regulation of defense response to virus by host (GO:0002230) | 3.14991795 |
71 | leukocyte mediated cytotoxicity (GO:0001909) | 3.14767231 |
72 | negative thymic T cell selection (GO:0045060) | 3.14689744 |
73 | * response to protozoan (GO:0001562) | 3.14331496 |
74 | dendritic cell differentiation (GO:0097028) | 3.13175868 |
75 | germinal center formation (GO:0002467) | 3.12817634 |
76 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.12768550 |
77 | natural killer cell activation (GO:0030101) | 3.12585020 |
78 | response to peptidoglycan (GO:0032494) | 3.11996560 |
79 | T cell migration (GO:0072678) | 3.11409802 |
80 | mature B cell differentiation involved in immune response (GO:0002313) | 3.11113525 |
81 | detection of external biotic stimulus (GO:0098581) | 3.11043912 |
82 | T cell selection (GO:0045058) | 3.10663446 |
83 | dendritic cell chemotaxis (GO:0002407) | 3.10402745 |
84 | regulation of type 2 immune response (GO:0002828) | 3.10343579 |
85 | myeloid cell activation involved in immune response (GO:0002275) | 3.10138338 |
86 | positive regulation of isotype switching (GO:0045830) | 3.07970286 |
87 | mast cell activation (GO:0045576) | 3.06140120 |
88 | T cell costimulation (GO:0031295) | 3.04582391 |
89 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.04130223 |
90 | * positive regulation of interleukin-12 production (GO:0032735) | 3.04074620 |
91 | response to interleukin-15 (GO:0070672) | 3.03444282 |
92 | regulation of mast cell degranulation (GO:0043304) | 3.03260922 |
93 | positive thymic T cell selection (GO:0045059) | 3.02243821 |
94 | positive regulation of interferon-beta production (GO:0032728) | 3.01984485 |
95 | response to host (GO:0075136) | 3.01724756 |
96 | response to host defenses (GO:0052200) | 3.01724756 |
97 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.01724756 |
98 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.01613903 |
99 | thymic T cell selection (GO:0045061) | 3.00634120 |
100 | lymphocyte costimulation (GO:0031294) | 2.99998023 |
101 | positive regulation of mast cell activation (GO:0033005) | 2.99789242 |
102 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.99489734 |
103 | * defense response to protozoan (GO:0042832) | 2.98957245 |
104 | response to interferon-beta (GO:0035456) | 2.97539832 |
105 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.97271730 |
106 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.96417337 |
107 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.96119946 |
108 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.95587577 |
109 | positive T cell selection (GO:0043368) | 2.95439122 |
110 | negative T cell selection (GO:0043383) | 2.95325626 |
111 | * response to interferon-gamma (GO:0034341) | 2.92901656 |
112 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.92804251 |
113 | negative regulation of T cell mediated immunity (GO:0002710) | 2.92534795 |
114 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.91091333 |
115 | cellular response to interleukin-15 (GO:0071350) | 2.90314078 |
116 | leukocyte aggregation (GO:0070486) | 2.88266072 |
117 | cellular defense response (GO:0006968) | 2.86409748 |
118 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.86077574 |
119 | positive regulation of mast cell degranulation (GO:0043306) | 2.86077574 |
120 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.85989183 |
121 | positive regulation of B cell mediated immunity (GO:0002714) | 2.85989183 |
122 | microglial cell activation (GO:0001774) | 2.85965422 |
123 | mature B cell differentiation (GO:0002335) | 2.85332112 |
124 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.84479293 |
125 | dendritic cell migration (GO:0036336) | 2.84240020 |
126 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.84215723 |
127 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.83833507 |
128 | regulation of interferon-beta production (GO:0032648) | 2.83633803 |
129 | negative regulation of granulocyte differentiation (GO:0030853) | 2.83038111 |
130 | regulation of response to interferon-gamma (GO:0060330) | 2.82934372 |
131 | cellular extravasation (GO:0045123) | 2.82829509 |
132 | myeloid leukocyte activation (GO:0002274) | 2.81850196 |
133 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.81783593 |
134 | B cell homeostasis (GO:0001782) | 2.81047595 |
135 | regulation of mast cell activation (GO:0033003) | 2.80399434 |
136 | natural killer cell differentiation (GO:0001779) | 2.78883564 |
137 | T cell proliferation (GO:0042098) | 2.78405687 |
138 | regulation of B cell proliferation (GO:0030888) | 2.78276663 |
139 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.77728044 |
140 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.77728044 |
141 | pinocytosis (GO:0006907) | 2.75853630 |
142 | negative regulation of cell killing (GO:0031342) | 2.75717796 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.06371766 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.41826968 |
3 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.22450660 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.46779033 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.17138668 |
6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.70249592 |
7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.62227945 |
8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.56899392 |
9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.46873842 |
10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.39954484 |
11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.37222135 |
12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.18095750 |
13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.06029254 |
14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.94537288 |
15 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.93299189 |
16 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.89502600 |
17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.75059635 |
18 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.56969069 |
19 | MYC_22102868_ChIP-Seq_BL_Human | 2.54410343 |
20 | MYB_26560356_Chip-Seq_TH2_Human | 2.44914221 |
21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.39015509 |
22 | MAF_26560356_Chip-Seq_TH1_Human | 2.28397478 |
23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.26668492 |
24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.22176900 |
25 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.17955944 |
26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.16315032 |
27 | * MYB_26560356_Chip-Seq_TH1_Human | 2.15609227 |
28 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.13214083 |
29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.10749564 |
30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.09112940 |
31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.04094289 |
32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03616219 |
33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.03548970 |
34 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.00073722 |
35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.95796109 |
36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.87513225 |
37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.78203552 |
38 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77877568 |
39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.72634562 |
40 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.68579869 |
41 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.67467810 |
42 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.65089648 |
43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.59260275 |
44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.56020092 |
45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52299033 |
46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51591203 |
47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.51331732 |
48 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48125970 |
49 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.46840839 |
50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43357735 |
51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.42681854 |
52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37402053 |
53 | MAF_26560356_Chip-Seq_TH2_Human | 1.36976775 |
54 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.36808061 |
55 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32029047 |
56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31216396 |
57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31144110 |
58 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30064786 |
59 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.25675543 |
60 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24103957 |
61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.23748605 |
62 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19800607 |
63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19327730 |
64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.16924325 |
65 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16094347 |
66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14742052 |
67 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.12692560 |
68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.09956936 |
69 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09325920 |
70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08330210 |
71 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.06792492 |
72 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06345344 |
73 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06111069 |
74 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.05632004 |
75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04227092 |
76 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.02885134 |
77 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02771748 |
78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02073678 |
79 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01648153 |
80 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00754801 |
81 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00455153 |
82 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99901177 |
83 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99171375 |
84 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97896627 |
85 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.97812594 |
86 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96263045 |
87 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94858625 |
88 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.94672708 |
89 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93829311 |
90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93382754 |
91 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.92064932 |
92 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92042986 |
93 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91636931 |
94 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.90638751 |
95 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90459331 |
96 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87616428 |
97 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.87213420 |
98 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.84572991 |
99 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81729648 |
100 | P300_27268052_Chip-Seq_Bcells_Human | 0.81398428 |
101 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.80997320 |
102 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.79885914 |
103 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.75780388 |
104 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74773897 |
105 | GATA1_19941826_ChIP-Seq_K562_Human | 0.73119634 |
106 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72855343 |
107 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.71274476 |
108 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.69382123 |
109 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.69314128 |
110 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.68229966 |
111 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.63294451 |
112 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.62208169 |
113 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.62203916 |
114 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.61582750 |
115 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61460686 |
116 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.61040329 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 5.64297427 |
2 | MP0005671_abnormal_response_to | 3.86301631 |
3 | MP0000685_abnormal_immune_system | 3.45187413 |
4 | MP0001790_abnormal_immune_system | 3.39832949 |
5 | MP0005387_immune_system_phenotype | 3.39832949 |
6 | * MP0001800_abnormal_humoral_immune | 3.26702088 |
7 | MP0009785_altered_susceptibility_to | 3.15651941 |
8 | MP0005000_abnormal_immune_tolerance | 3.05477947 |
9 | MP0002148_abnormal_hypersensitivity_rea | 3.03755706 |
10 | MP0003436_decreased_susceptibility_to | 2.97702344 |
11 | MP0003303_peritoneal_inflammation | 2.94905895 |
12 | * MP0002452_abnormal_antigen_presenting | 2.92903234 |
13 | * MP0005025_abnormal_response_to | 2.80564688 |
14 | MP0006082_CNS_inflammation | 2.76743867 |
15 | * MP0002723_abnormal_immune_serum | 2.74966412 |
16 | MP0002419_abnormal_innate_immunity | 2.64731883 |
17 | * MP0001819_abnormal_immune_cell | 2.64401684 |
18 | * MP0002420_abnormal_adaptive_immunity | 2.63921940 |
19 | MP0002166_altered_tumor_susceptibility | 2.51705925 |
20 | MP0002396_abnormal_hematopoietic_system | 2.30913353 |
21 | * MP0002398_abnormal_bone_marrow | 2.26435779 |
22 | MP0004510_myositis | 2.18165022 |
23 | MP0003763_abnormal_thymus_physiology | 2.17233910 |
24 | * MP0000716_abnormal_immune_system | 2.16167107 |
25 | MP0001853_heart_inflammation | 2.15377632 |
26 | MP0002006_tumorigenesis | 2.15294007 |
27 | MP0002405_respiratory_system_inflammati | 2.06312766 |
28 | MP0001873_stomach_inflammation | 2.00219396 |
29 | MP0010155_abnormal_intestine_physiology | 1.91522380 |
30 | * MP0000689_abnormal_spleen_morphology | 1.88803395 |
31 | MP0005464_abnormal_platelet_physiology | 1.88081112 |
32 | MP0003300_gastrointestinal_ulcer | 1.87682282 |
33 | MP0009333_abnormal_splenocyte_physiolog | 1.83552320 |
34 | MP0001845_abnormal_inflammatory_respons | 1.83153407 |
35 | * MP0002429_abnormal_blood_cell | 1.78060880 |
36 | MP0005451_abnormal_body_composition | 1.76720258 |
37 | * MP0002722_abnormal_immune_system | 1.75386820 |
38 | MP0005310_abnormal_salivary_gland | 1.75155904 |
39 | MP0008057_abnormal_DNA_replication | 1.65574342 |
40 | MP0003724_increased_susceptibility_to | 1.52147493 |
41 | MP0010307_abnormal_tumor_latency | 1.50442264 |
42 | MP0003172_abnormal_lysosome_physiology | 1.48191876 |
43 | MP0003448_altered_tumor_morphology | 1.48062398 |
44 | MP0005058_abnormal_lysosome_morphology | 1.46700413 |
45 | MP0008469_abnormal_protein_level | 1.44396698 |
46 | MP0000703_abnormal_thymus_morphology | 1.42726572 |
47 | MP0004947_skin_inflammation | 1.38726535 |
48 | MP0003866_abnormal_defecation | 1.38504454 |
49 | MP0004808_abnormal_hematopoietic_stem | 1.37595332 |
50 | MP0000858_altered_metastatic_potential | 1.34529927 |
51 | MP0001533_abnormal_skeleton_physiology | 1.33055386 |
52 | MP0003183_abnormal_peptide_metabolism | 1.31722858 |
53 | MP0002138_abnormal_hepatobiliary_system | 1.26192744 |
54 | MP0005397_hematopoietic_system_phenotyp | 1.24395679 |
55 | MP0001545_abnormal_hematopoietic_system | 1.24395679 |
56 | MP0000490_abnormal_crypts_of | 1.19546924 |
57 | MP0005174_abnormal_tail_pigmentation | 1.17546078 |
58 | MP0003191_abnormal_cellular_cholesterol | 1.15495877 |
59 | MP0002139_abnormal_hepatobiliary_system | 1.11935296 |
60 | MP0002254_reproductive_system_inflammat | 1.11384127 |
61 | MP0009764_decreased_sensitivity_to | 1.08773287 |
62 | MP0000465_gastrointestinal_hemorrhage | 1.07754560 |
63 | MP0000343_altered_response_to | 1.06716995 |
64 | MP0009278_abnormal_bone_marrow | 0.98884433 |
65 | MP0008260_abnormal_autophagy | 0.96827689 |
66 | MP0000569_abnormal_digit_pigmentation | 0.96263618 |
67 | MP0009840_abnormal_foam_cell | 0.95906276 |
68 | MP0001348_abnormal_lacrimal_gland | 0.95092194 |
69 | MP0010352_gastrointestinal_tract_polyps | 0.94786988 |
70 | * MP0002019_abnormal_tumor_incidence | 0.93520040 |
71 | MP0000015_abnormal_ear_pigmentation | 0.92242302 |
72 | MP0003690_abnormal_glial_cell | 0.89506864 |
73 | MP0000371_diluted_coat_color | 0.85119802 |
74 | MP0002933_joint_inflammation | 0.84332488 |
75 | * MP0009763_increased_sensitivity_to | 0.82216407 |
76 | MP0010094_abnormal_chromosome_stability | 0.82166031 |
77 | MP0004883_abnormal_blood_vessel | 0.81761031 |
78 | MP0008004_abnormal_stomach_pH | 0.81503952 |
79 | MP0002998_abnormal_bone_remodeling | 0.81228610 |
80 | MP0003656_abnormal_erythrocyte_physiolo | 0.79917481 |
81 | MP0003693_abnormal_embryo_hatching | 0.78897701 |
82 | MP0000604_amyloidosis | 0.78100029 |
83 | MP0003077_abnormal_cell_cycle | 0.74673266 |
84 | MP0002009_preneoplasia | 0.73375981 |
85 | MP0001663_abnormal_digestive_system | 0.73243520 |
86 | MP0001851_eye_inflammation | 0.72971822 |
87 | MP0000249_abnormal_blood_vessel | 0.72720788 |
88 | MP0003075_altered_response_to | 0.71763556 |
89 | MP0003828_pulmonary_edema | 0.71355704 |
90 | MP0005076_abnormal_cell_differentiation | 0.70025742 |
91 | MP0005075_abnormal_melanosome_morpholog | 0.69791599 |
92 | MP0004782_abnormal_surfactant_physiolog | 0.69641455 |
93 | MP0005166_decreased_susceptibility_to | 0.68106690 |
94 | MP0002095_abnormal_skin_pigmentation | 0.63552882 |
95 | MP0002928_abnormal_bile_duct | 0.61820776 |
96 | MP0003453_abnormal_keratinocyte_physiol | 0.60491308 |
97 | MP0002136_abnormal_kidney_physiology | 0.59161939 |
98 | MP0005164_abnormal_response_to | 0.58539981 |
99 | MP0002332_abnormal_exercise_endurance | 0.57250089 |
100 | MP0008874_decreased_physiological_sensi | 0.56978473 |
101 | MP0006054_spinal_hemorrhage | 0.54799927 |
102 | MP0008873_increased_physiological_sensi | 0.54763893 |
103 | MP0008007_abnormal_cellular_replicative | 0.54685531 |
104 | MP0002876_abnormal_thyroid_physiology | 0.54447212 |
105 | MP0009765_abnormal_xenobiotic_induced | 0.54177270 |
106 | MP0002693_abnormal_pancreas_physiology | 0.53847005 |
107 | MP0000313_abnormal_cell_death | 0.53428899 |
108 | MP0003795_abnormal_bone_structure | 0.53390534 |
109 | MP0003806_abnormal_nucleotide_metabolis | 0.51632070 |
110 | MP0003091_abnormal_cell_migration | 0.51363958 |
111 | MP0008058_abnormal_DNA_repair | 0.51243388 |
112 | MP0002132_abnormal_respiratory_system | 0.50022829 |
113 | MP0005390_skeleton_phenotype | 0.49760350 |
114 | MP0000609_abnormal_liver_physiology | 0.49263448 |
115 | MP0002163_abnormal_gland_morphology | 0.48622078 |
116 | MP0005535_abnormal_body_temperature | 0.47749277 |
117 | MP0005381_digestive/alimentary_phenotyp | 0.47510170 |
118 | MP0003045_fibrosis | 0.47148552 |
119 | MP0002277_abnormal_respiratory_mucosa | 0.46449425 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.47920841 |
2 | Recurrent bacterial skin infections (HP:0005406) | 5.33674294 |
3 | Eczematoid dermatitis (HP:0000976) | 5.06443005 |
4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.85299608 |
5 | Recurrent viral infections (HP:0004429) | 4.69433574 |
6 | Chronic otitis media (HP:0000389) | 4.60349926 |
7 | Agammaglobulinemia (HP:0004432) | 4.38355153 |
8 | Recurrent fungal infections (HP:0002841) | 4.36405388 |
9 | Myositis (HP:0100614) | 4.20659208 |
10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.20372306 |
11 | Meningitis (HP:0001287) | 4.05522425 |
12 | Recurrent cutaneous fungal infections (HP:0011370) | 3.95890007 |
13 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.95890007 |
14 | Recurrent skin infections (HP:0001581) | 3.95877290 |
15 | Colitis (HP:0002583) | 3.92633210 |
16 | Thrombocytosis (HP:0001894) | 3.88304818 |
17 | Abnormality of macrophages (HP:0004311) | 3.85661551 |
18 | Recurrent bronchitis (HP:0002837) | 3.84193985 |
19 | Mediastinal lymphadenopathy (HP:0100721) | 3.81226956 |
20 | Cellulitis (HP:0100658) | 3.78101008 |
21 | IgM deficiency (HP:0002850) | 3.75842908 |
22 | Panhypogammaglobulinemia (HP:0003139) | 3.72787583 |
23 | Vasculitis (HP:0002633) | 3.68324822 |
24 | Inflammation of the large intestine (HP:0002037) | 3.67387454 |
25 | Gastrointestinal inflammation (HP:0004386) | 3.54824613 |
26 | Nasal polyposis (HP:0100582) | 3.50784240 |
27 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.45523517 |
28 | Abnormality of T cell physiology (HP:0011840) | 3.38570230 |
29 | Obstructive lung disease (HP:0006536) | 3.30048434 |
30 | Chronic obstructive pulmonary disease (HP:0006510) | 3.30048434 |
31 | Spontaneous hematomas (HP:0007420) | 3.24034752 |
32 | Autoimmune thrombocytopenia (HP:0001973) | 3.20139665 |
33 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.15314367 |
34 | Encephalitis (HP:0002383) | 3.03442214 |
35 | Gastrointestinal stroma tumor (HP:0100723) | 3.03355043 |
36 | Abnormality of the nasal mucosa (HP:0000433) | 3.00207348 |
37 | Abnormality of T cells (HP:0002843) | 2.97195131 |
38 | Urticaria (HP:0001025) | 2.92876929 |
39 | Interstitial pulmonary disease (HP:0006530) | 2.89288101 |
40 | Basal ganglia calcification (HP:0002135) | 2.86134722 |
41 | Orchitis (HP:0100796) | 2.83700301 |
42 | Recurrent pneumonia (HP:0006532) | 2.82935022 |
43 | Recurrent lower respiratory tract infections (HP:0002783) | 2.81170151 |
44 | Chronic sinusitis (HP:0011109) | 2.79503982 |
45 | Eosinophilia (HP:0001880) | 2.78973501 |
46 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.77338216 |
47 | Lymphopenia (HP:0001888) | 2.77102219 |
48 | Periodontitis (HP:0000704) | 2.76554603 |
49 | Optic neuritis (HP:0100653) | 2.76550823 |
50 | Retrobulbar optic neuritis (HP:0100654) | 2.76550823 |
51 | Restrictive lung disease (HP:0002091) | 2.76446281 |
52 | Pulmonary infiltrates (HP:0002113) | 2.75263553 |
53 | Osteomyelitis (HP:0002754) | 2.74401438 |
54 | Systemic lupus erythematosus (HP:0002725) | 2.68712451 |
55 | Recurrent sinusitis (HP:0011108) | 2.68168395 |
56 | IgA deficiency (HP:0002720) | 2.68152598 |
57 | Gingivitis (HP:0000230) | 2.67795064 |
58 | Hypergammaglobulinemia (HP:0010702) | 2.66511785 |
59 | Increased cerebral lipofuscin (HP:0011813) | 2.66477309 |
60 | Skin rash (HP:0000988) | 2.62782163 |
61 | Autoimmune hemolytic anemia (HP:0001890) | 2.62015298 |
62 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.61099830 |
63 | Chronic diarrhea (HP:0002028) | 2.57759145 |
64 | IgG deficiency (HP:0004315) | 2.55350177 |
65 | Emphysema (HP:0002097) | 2.55177005 |
66 | Granulocytopenia (HP:0001913) | 2.55161791 |
67 | Increased IgE level (HP:0003212) | 2.54319301 |
68 | Pustule (HP:0200039) | 2.53511177 |
69 | Abnormality of the pleura (HP:0002103) | 2.52973793 |
70 | Abnormality of the fingertips (HP:0001211) | 2.45923127 |
71 | Dysostosis multiplex (HP:0000943) | 2.44622248 |
72 | B lymphocytopenia (HP:0010976) | 2.41998062 |
73 | Abnormality of B cell number (HP:0010975) | 2.41998062 |
74 | Abnormality of T cell number (HP:0011839) | 2.41782810 |
75 | Spinal cord lesions (HP:0100561) | 2.38482790 |
76 | Syringomyelia (HP:0003396) | 2.38482790 |
77 | Lymphoma (HP:0002665) | 2.37740504 |
78 | Absent frontal sinuses (HP:0002688) | 2.37697180 |
79 | Thyroiditis (HP:0100646) | 2.36995296 |
80 | Chest pain (HP:0100749) | 2.36846040 |
81 | Gastrointestinal infarctions (HP:0005244) | 2.35340527 |
82 | Increased IgM level (HP:0003496) | 2.33750974 |
83 | Leukopenia (HP:0001882) | 2.33550799 |
84 | Hemoptysis (HP:0002105) | 2.33382828 |
85 | Verrucae (HP:0200043) | 2.32318618 |
86 | Papilloma (HP:0012740) | 2.32318618 |
87 | Gangrene (HP:0100758) | 2.31655952 |
88 | Amyloidosis (HP:0011034) | 2.31026343 |
89 | Skin ulcer (HP:0200042) | 2.30339474 |
90 | Petechiae (HP:0000967) | 2.29362782 |
91 | Arterial thrombosis (HP:0004420) | 2.29312838 |
92 | Leukocytosis (HP:0001974) | 2.27293607 |
93 | Agnosia (HP:0010524) | 2.26668728 |
94 | Keratoconjunctivitis (HP:0001096) | 2.25527292 |
95 | Vacuolated lymphocytes (HP:0001922) | 2.24297965 |
96 | T lymphocytopenia (HP:0005403) | 2.24060009 |
97 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.23989966 |
98 | Sepsis (HP:0100806) | 2.21586794 |
99 | Stomatitis (HP:0010280) | 2.20659635 |
100 | Hematochezia (HP:0002573) | 2.17690518 |
101 | Papilledema (HP:0001085) | 2.16444445 |
102 | Abnormality of eosinophils (HP:0001879) | 2.15861555 |
103 | Viral hepatitis (HP:0006562) | 2.15501406 |
104 | Keratoconjunctivitis sicca (HP:0001097) | 2.14677515 |
105 | Loss of speech (HP:0002371) | 2.13962562 |
106 | Arthralgia (HP:0002829) | 2.13381784 |
107 | Hypertensive crisis (HP:0100735) | 2.13177569 |
108 | Disinhibition (HP:0000734) | 2.11419445 |
109 | Fatigue (HP:0012378) | 2.08731887 |
110 | Abnormality of the prostate (HP:0008775) | 2.08712333 |
111 | Pulmonary embolism (HP:0002204) | 2.08574628 |
112 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.06842388 |
113 | Abnormality of glycolipid metabolism (HP:0010969) | 2.06842388 |
114 | Epistaxis (HP:0000421) | 2.04792963 |
115 | Combined immunodeficiency (HP:0005387) | 2.04359779 |
116 | Polyneuropathy (HP:0001271) | 2.03382601 |
117 | Purpura (HP:0000979) | 2.00504394 |
118 | Severe combined immunodeficiency (HP:0004430) | 1.98059426 |
119 | Abnormality of the peritoneum (HP:0002585) | 1.97812647 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.90848935 |
2 | MAP3K14 | 3.88413486 |
3 | TYK2 | 3.42839535 |
4 | BLK | 3.38375338 |
5 | IRAK4 | 2.90591241 |
6 | TBK1 | 2.82105086 |
7 | PRPF4B | 2.75429517 |
8 | JAK3 | 2.70194979 |
9 | KIT | 2.68833836 |
10 | CSF1R | 2.44080542 |
11 | JAK1 | 2.37855850 |
12 | IKBKB | 2.19144408 |
13 | TXK | 2.18591311 |
14 | IKBKE | 2.12122727 |
15 | SYK | 2.08111900 |
16 | ZAP70 | 2.03071471 |
17 | IRAK3 | 2.00995535 |
18 | BTK | 1.96350229 |
19 | RIPK4 | 1.92801713 |
20 | MAP3K13 | 1.91326913 |
21 | CLK1 | 1.77248729 |
22 | ERN1 | 1.76043297 |
23 | TEC | 1.68230005 |
24 | TAOK3 | 1.59535522 |
25 | CSK | 1.55714734 |
26 | CHUK | 1.51020250 |
27 | PIM2 | 1.50723384 |
28 | STK10 | 1.50602136 |
29 | FES | 1.50328472 |
30 | EPHB1 | 1.50046682 |
31 | MAP3K10 | 1.48707452 |
32 | GRK6 | 1.44375936 |
33 | ITK | 1.35493380 |
34 | LYN | 1.31138288 |
35 | PIM1 | 1.29822605 |
36 | LCK | 1.28793750 |
37 | HCK | 1.26100492 |
38 | EEF2K | 1.23361943 |
39 | RPS6KA4 | 1.21458899 |
40 | FGR | 1.19882564 |
41 | FLT3 | 1.16140702 |
42 | FGFR4 | 1.12493832 |
43 | MAP2K3 | 1.11559357 |
44 | TGFBR2 | 1.11457390 |
45 | LRRK2 | 1.10100523 |
46 | TAOK2 | 1.08785225 |
47 | CDC42BPA | 0.99469567 |
48 | FGFR3 | 0.94878075 |
49 | MOS | 0.93310297 |
50 | JAK2 | 0.89973574 |
51 | GRK7 | 0.88915918 |
52 | SMG1 | 0.87561895 |
53 | MST4 | 0.86575049 |
54 | MAPK12 | 0.85127522 |
55 | SIK3 | 0.81922369 |
56 | NEK9 | 0.80482034 |
57 | STK4 | 0.80050346 |
58 | MAPK7 | 0.78333688 |
59 | MATK | 0.78193400 |
60 | TAOK1 | 0.77556014 |
61 | MAP3K1 | 0.75347341 |
62 | SIK2 | 0.73169474 |
63 | NLK | 0.72459091 |
64 | MAP3K8 | 0.70980855 |
65 | CDK12 | 0.69115440 |
66 | TRPM7 | 0.68422183 |
67 | PRKCQ | 0.67243134 |
68 | IRAK2 | 0.66560127 |
69 | CDK4 | 0.65713662 |
70 | EIF2AK3 | 0.64695132 |
71 | MAP3K3 | 0.63590442 |
72 | EPHA3 | 0.60561751 |
73 | MARK3 | 0.60310079 |
74 | CDK19 | 0.60193339 |
75 | ARAF | 0.58635588 |
76 | SCYL2 | 0.55150316 |
77 | TRIB3 | 0.54901121 |
78 | ATR | 0.54498857 |
79 | NME2 | 0.53963814 |
80 | ADRBK2 | 0.52187259 |
81 | RPS6KA6 | 0.50892151 |
82 | ABL1 | 0.49660257 |
83 | PDPK1 | 0.49053730 |
84 | KDR | 0.43407692 |
85 | MAPKAPK2 | 0.43382783 |
86 | BMPR2 | 0.43292520 |
87 | NEK2 | 0.42760045 |
88 | PRKCD | 0.41668232 |
89 | EIF2AK1 | 0.40452693 |
90 | EGFR | 0.40211774 |
91 | EIF2AK2 | 0.39525706 |
92 | MAP3K5 | 0.39010164 |
93 | CDK6 | 0.38932894 |
94 | MAPK4 | 0.38156050 |
95 | PTK6 | 0.38139790 |
96 | RPS6KC1 | 0.37778567 |
97 | RPS6KL1 | 0.37778567 |
98 | MAPK11 | 0.37567316 |
99 | HIPK2 | 0.33907963 |
100 | PDK1 | 0.33421377 |
101 | PASK | 0.32865128 |
102 | FYN | 0.32797107 |
103 | NUAK1 | 0.31792820 |
104 | DDR2 | 0.30866272 |
105 | PAK4 | 0.30499266 |
106 | IRAK1 | 0.28192678 |
107 | MARK2 | 0.28041320 |
108 | MAP3K11 | 0.27480740 |
109 | SIK1 | 0.26215815 |
110 | KSR2 | 0.24899801 |
111 | ALK | 0.24508600 |
112 | RIPK1 | 0.24431894 |
113 | TNK2 | 0.23723129 |
114 | TSSK6 | 0.23398472 |
115 | RPS6KA5 | 0.23080804 |
116 | VRK1 | 0.23064827 |
117 | MAP2K2 | 0.22538727 |
118 | YES1 | 0.21710062 |
119 | PIK3CG | 0.21153486 |
120 | PKN2 | 0.20592940 |
121 | INSR | 0.19606536 |
122 | RAF1 | 0.18359993 |
123 | MAPK3 | 0.17536243 |
124 | TESK2 | 0.17079980 |
125 | MAP2K6 | 0.16932003 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Allograft rejection_Homo sapiens_hsa05330 | 3.54799927 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.34648269 |
3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.19507022 |
4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.80701264 |
5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.65887900 |
6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.62652140 |
7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.57192019 |
8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.51125700 |
9 | Measles_Homo sapiens_hsa05162 | 2.38551607 |
10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.31976196 |
11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.29681551 |
12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.21789077 |
13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.17571341 |
14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.12976163 |
15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.09411437 |
16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.02027256 |
17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.97135789 |
18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.89849668 |
19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.79148685 |
20 | Influenza A_Homo sapiens_hsa05164 | 1.78817811 |
21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.71612327 |
22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.67831309 |
23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.62992965 |
24 | Tuberculosis_Homo sapiens_hsa05152 | 1.62070642 |
25 | DNA replication_Homo sapiens_hsa03030 | 1.61521640 |
26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.54616943 |
27 | * Pertussis_Homo sapiens_hsa05133 | 1.53642599 |
28 | Legionellosis_Homo sapiens_hsa05134 | 1.53247082 |
29 | Apoptosis_Homo sapiens_hsa04210 | 1.51648461 |
30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48660302 |
31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.41492136 |
32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40434474 |
33 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.39083047 |
34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37480149 |
35 | Shigellosis_Homo sapiens_hsa05131 | 1.35029769 |
36 | Malaria_Homo sapiens_hsa05144 | 1.34298690 |
37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.33222588 |
38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.29825836 |
39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29221594 |
40 | Hepatitis B_Homo sapiens_hsa05161 | 1.28596214 |
41 | Asthma_Homo sapiens_hsa05310 | 1.25378100 |
42 | Base excision repair_Homo sapiens_hsa03410 | 1.24653173 |
43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.22080570 |
44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.16731549 |
45 | Mismatch repair_Homo sapiens_hsa03430 | 1.10955082 |
46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09451416 |
47 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.05360561 |
48 | Salmonella infection_Homo sapiens_hsa05132 | 1.04533768 |
49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98839486 |
50 | Lysosome_Homo sapiens_hsa04142 | 0.96972490 |
51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94997626 |
52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94536488 |
53 | Hepatitis C_Homo sapiens_hsa05160 | 0.91958364 |
54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.88267424 |
55 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.87627442 |
56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83089451 |
57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77087674 |
58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76936893 |
59 | Homologous recombination_Homo sapiens_hsa03440 | 0.74813893 |
60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74670378 |
61 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73862355 |
62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72179236 |
63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69702145 |
64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69186792 |
65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68607149 |
66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67268619 |
67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67036376 |
68 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.65710451 |
69 | Platelet activation_Homo sapiens_hsa04611 | 0.64819344 |
70 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63966794 |
71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59817248 |
72 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58230418 |
73 | Phagosome_Homo sapiens_hsa04145 | 0.55883626 |
74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54940971 |
75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51414418 |
76 | Ribosome_Homo sapiens_hsa03010 | 0.42712419 |
77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39025612 |
78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.36653708 |
79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35637026 |
80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34739489 |
81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33413491 |
82 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.33078386 |
83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31432210 |
84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31357779 |
85 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.29610831 |
86 | Spliceosome_Homo sapiens_hsa03040 | 0.29582597 |
87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29475783 |
88 | ABC transporters_Homo sapiens_hsa02010 | 0.29365659 |
89 | Amoebiasis_Homo sapiens_hsa05146 | 0.28186539 |
90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27302454 |
91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.26261329 |
92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25294686 |
93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.25154821 |
94 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.24456493 |
95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.23713361 |
96 | Cell cycle_Homo sapiens_hsa04110 | 0.23279394 |
97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20815285 |
98 | Endocytosis_Homo sapiens_hsa04144 | 0.20571187 |
99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.19547528 |
100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.19345230 |
101 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.18808703 |
102 | Proteasome_Homo sapiens_hsa03050 | 0.18626392 |
103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.18441531 |
104 | Bladder cancer_Homo sapiens_hsa05219 | 0.17004550 |
105 | Insulin resistance_Homo sapiens_hsa04931 | 0.16300066 |
106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.16220734 |
107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.15333916 |
108 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.15078965 |
109 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.14102183 |
110 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.09912673 |
111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.09089535 |
112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08999437 |
113 | Prostate cancer_Homo sapiens_hsa05215 | 0.08775723 |
114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.07166414 |
115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.06323812 |
116 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.05117454 |
117 | Prion diseases_Homo sapiens_hsa05020 | 0.04569490 |
118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.03348694 |
119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.02606637 |